Home
Categories
Pharmaceutical
Hi Tech Manufacturing
Food
Finance
Design & Build
Containment
Cleaning
Sustainability
HVAC
Personal Protection
Regulatory
CT CONFERENCE
Company News
Events
Directory
Search
Close search
Home
Company
WuXi Biologics
WuXi Biologics
Activities:
Drug Delivery
Pharmaceutical
X
LinkedIn
Trending Articles
New material captures coronavirus particles to boost face mask efficiency
Researchers at the University of Liverpool have looked to significantly boost face mask efficiency by developing a new material that captures coronavirus particles
Case Study: Building a mobile cleanroom for electronic grade sulfuric acid production
Mark Koers from Modular Devices discusses creating a mobile solution for Chemtrade’s ultrapure sulfuric acid US production capabilities
Cleanroom cleaning: the challenge of sustainable wipes
When it comes to going green in the cleanroom, there are challenges for the consumables landscape. Contec is expanding its recycled polyester cleanroom wipe range, ReFIBE, to...
The cleanroom market in Southeast Asia in 2024
A look at the cleanroom sector in Southeast Asia, which is facing a slowing semiconductor market, as well as increasing competition in the construction space
Guide to commissioning and qualification
The specific steps companies should follow to complete a cleanroom project, be it a new build or upgrade, are explained in this guide by Mack Powers, Integrao President
Upcoming event
Cleanroom Technology Webinar Roundtables Series - DESIGN & BUILD
27 March 2024 | Webinar | 15:00 GMT
See all
Related Content
Pharmaceutical
WuXi Biologics plans to build a comprehensive CRDMO centre in Singapore
This investment will establish a cutting-edge, fully integrated CRDMO centre in Singapore and strenghten WuXi Biologics’ global research, development and manufacturing network
Design & Build
WuXi Biologics closes deal to build biomanufacturing hub in the US
China-based WuXi Biologics has agreed to build its 107,000 sqft clinical and commercial manufacturing facility in Worcester, US
Design & Build
WuXi completes weather-tight seal of Irish biologics facility
WuXi Biologics has completed the seal of its first global supply facility in Europe that began construction in February 2019
Design & Build
WuXi invests $240m in Irish CDMO operations
WuXi Vaccines, a subsidiary of China-based WuXi Biologics, will spend $240m to build a dedicated vaccine manufacturing facility
Design & Build
WBDC demolishes hospital for WuXi potential biomanufacturing centre
Worcester Business Development Corp has received $15m from the state to demolish the 380,000 sqft section of a vacant hospital in Massachusetts
Manufacturing
WuXi Biologics CEO: Vaccine CDMO is the next area of growth
Dr Chris Chen launches WuXi Vaccines, announces new facility and a 20-year manufacturing contract worth US$3 billion
Research & Development
Swiss NBE-Therapeutics chooses WuXi Biologics as manufacturing partner
Chinese-Swiss partnership will focus on development and manufacturing capacity of immune-stimulatory ADC treatment against the ROR1 cancer target
Subscribe now